Search Main Menu Main Content
  • Change contrast :
Retour à l'accueil du site de la HAS
logo HAS
icone
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. Industriels
  2. Médicament
  3. RANIPLEX (ranitidine)
  • icone plus
  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

    Mon Compte
  • No element in selection

    Favoris
  • Établissements de santé
  • Contact Abonnez-vous aux actualités
Listen Listen
Add to my selection
  • History
  • Technical informations
Share
Share on
Facebook share - facebook.com - new window
Tweeter share - Partager sur Twitter - twitter.com - new window
LinkedIn share - linkedin.com - new window
Print

RANIPLEX (ranitidine)

Medicine - Posted on Apr 08 2013 - Updated on Jun 12 2019
Active substance (DCI)
  • ranitidine
history (6)
  • 3/6/13

    RANIPLEX (ranitidine)

    RANIPLEX (ranitidine)
    icône flèche
  • 10/19/11

    RANIPLEX (ranitidine)

    RANIPLEX (ranitidine)
    icône flèche
  • 5/14/08

    RANIPLEX (ranitidine)

    RANIPLEX (ranitidine)
    icône flèche
  • 6/26/02

    RANIPLEX 75 mg, comprimés pelliculés (B/14 - B/28)RANIPLEX 75 mg, comprimés effervescents (B/14 - B/28)

    RANIPLEX 75 mg, comprimés pelliculés (B/14 - B/28)RANIPLEX 75 mg, comprimés effervescents (B/14 - B/28)
    icône flèche
  • 6/26/02

    RANIPLEX 300 mg, comprimé pelliculé - B/14RANIPLEX 300 mg, comprimé effervescent - B/14RANIPLEX 300 mg, granulé effervescent en sachet - B/14 (ranitidine)

    RANIPLEX 300 mg, comprimé pelliculé - B/14RANIPLEX 300 mg, comprimé effervescent - B/14RANIPLEX 300 mg, granulé effervescent en sachet - B/14 (ranitidine)
    icône flèche
  • 6/26/02

    RANIPLEX 150 mg, granulé effervescent B/30RANIPLEX 150 mg, comprimé effervescent B/30 (ranitidine)

    RANIPLEX 150 mg, granulé effervescent B/30RANIPLEX 150 mg, comprimé effervescent B/30 (ranitidine)
    icône flèche
Technical information
ATC code
  • A02BA02
Manufacturer
ABBOTT PRODUCTS SAS
Presentation

RANIPLEX 150 mg, comprimé effervescent B/30 - Code CIP : 3400933228798

RANIPLEX 300 mg, comprimé effervescent B/14 - Code CIP : 3400934369568

All our publications
    Drug therapy Esophageal and gastrointestinal diseases Paediatrics

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
Haute Autorité de Santé
Advancing quality in the fields of health and social care services
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • Français
  • English
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
gK4UqMmKjUz0zZyL